Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort

被引:22
作者
de Jonge, P. J. F.
Wolters, L. M. M.
Steyerberg, E. W.
Van Dekken, H.
Kusters, J. G.
Kuipers, E. J.
Siersema, P. D.
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[3] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands
关键词
D O I
10.1111/j.1365-2036.2007.03344.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Risk factors for adenocarcinoma of the oesophagus (OAC) and gastric cardia (GCA) are not yet established. Aim To compare environmental risk factors between patients with OAC and GCA. Methods One-hundred and twenty-six patients with OAC, 43 with GCA and 57 with squamous cell carcinoma filled out a questionnaire with information on demographic and lifestyle characteristics, physical activity levels, family history, gastro-oesophageal reflux disease symptoms and medication use. Results OAC and GCA patients were similar with regard to male predominance and age, alcohol intake and smoking, use of fruits and vegetables, body posture and occupational activities (P > 0.05). GCA patients less often had heartburn compared with OAC patients [odds ratio (OR) 0.5, 95% confidence interval (CI) 0.2-0.96] and had these symptoms less frequently and for a shorter period (OR 0.3, CI 0.1-1.0 and OR 0.1, CI 0.03-0.6, respectively). Former and current aspirin use was lower among GCA patients than OAC patients (OR 0.2, CI 0.05-0.7 and OR 0.4, CI 0.1-0.9, respectively), whereas no difference in non-steroidal anti-inflammatory drug use was detected. Conclusions Although OAC and GCA share several environmental risk factors, OAC is more frequently associated with a history of gastro-oesophageal reflux disease, suggesting a more important role for gastro-oesophageal reflux in OAC compared with GCA.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 30 条
[21]   Epidemiology of esophageal adenocarcinoma [J].
Pera, M ;
Manterola, C ;
Vidal, O ;
Grande, L .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 92 (03) :151-159
[22]  
Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888
[23]  
Siewert JR, 1998, BRIT J SURG, V85, P1457
[24]  
Souza RF, 2000, CANCER RES, V60, P5767
[25]   BARRETTS-ESOPHAGUS [J].
SPECHLER, SJ ;
GOYAL, RK .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (06) :362-371
[26]   Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett"s oesophagus: a prospective study [J].
Vaughan, TL ;
Dong, LM ;
Blount, PL ;
Ayub, K ;
Odze, RD ;
Sanchez, CA ;
Rabinovitch, PS ;
Reid, BJ .
LANCET ONCOLOGY, 2005, 6 (12) :945-952
[27]  
VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85
[28]   Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction [J].
Westerterp, M ;
Koppert, LB ;
Buskens, CJ ;
Tilanus, HW ;
ten Kate, FJW ;
Bergman, JJHGM ;
Siersema, PD ;
van Dekken, H ;
van Lanschot, JJB .
VIRCHOWS ARCHIV, 2005, 446 (05) :497-504
[29]   Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity [J].
Wijnhoven, BPL ;
Siersema, PD ;
Hop, WCJ ;
van Dekken, H ;
Tilanus, HW .
BRITISH JOURNAL OF SURGERY, 1999, 86 (04) :529-535
[30]  
[No title captured]